Friday, July 10, 2026

pharma · Hemophilia · Gaucher's disease type I; Gaucher's disease type III

Genzyme Europe

News and analysis for Genzyme Europe on NovaPharmaNews — regulatory, clinical, and market coverage.

NL HQ
1981 Founded
273 Employees
EMA registrant Type
Company details
Status
Public
HQ
NL
Founded
1981
Employees
273
Programs
5
Drugs
10
Patents
0
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Genzyme Europe — regulatory, clinical, and market coverage.

News and analysis for Genzyme Europe on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Genzyme Europe yet.

Back to company overview →